Specimen sorting systems market seen reaching $2.6B by 2030

The specimen sorting systems market is projected to grow from $1.63 billion in 2025 to $2.6 billion by 2030 as laboratories push harder on automation, speed and accuracy. The Business Research Company points to rising diagnostic testing, chronic disease prevalence and AI-enabled workflow tools as the main growth drivers.

Why it matters: - Clinical laboratories and diagnostic centers are under pressure to process more samples faster with fewer errors. - Specimen sorting systems automate sample classification, identification and routing, which can improve accuracy, traceability and turnaround times. - The market’s projected growth signals continued demand for lab automation across healthcare systems.

What happened: - The Business Research Company released its Specimen Sorting Systems Market Report 2026, covering market size, trends and global forecasts for 2026 to 2035. - The report says the market was worth $1.63 billion in 2025 and is projected to reach $1.79 billion in 2026. - The report forecasts the market will reach $2.6 billion by 2030. - The report puts the market’s CAGR at 9.6% for the near term and 9.9% through 2030. - The report was published July 22, 2026, from London. - Download a free sample of the report. - View the full specimen sorting systems market report.

The details: - Specimen sorting systems are automated technologies used to classify, identify and route biological samples in laboratory environments. - The systems reduce human error and manual labor in specimen handling. - The systems support traceability and faster turnaround times in diagnostic and testing workflows. - Growth in the market has been fueled by higher diagnostic testing volumes, a push for laboratory automation, manual handling errors, the need for faster diagnostic turnaround and expanding hospital and diagnostic lab infrastructure. - The report says AI-driven automation, robotics integration in specimen handling and smart laboratory ecosystems will support future growth. - A cited example from the U.S. Department of Health and Human Services Office of Inspector General showed genetic tests reimbursed under Medicare Part B rose 41% from 2022 to 2023. - Another cited example from the Centers for Disease Control and Prevention showed U.S. tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, future trend analysis and updated graphics and tables.

Between the lines: - Rising test volumes and disease burden are reinforcing the case for automation in lab operations. - The combination of robotics, AI and connected lab systems suggests the market is shifting from point solutions toward broader smart-lab infrastructure. - North America’s lead likely reflects its more mature healthcare and automation base, while Asia-Pacific’s faster growth points to new capacity being built out.

What's next: - The market is expected to keep expanding through 2030 as labs seek efficiency gains and more reliable sample workflows. - Investment is likely to follow regions and providers building diagnostic capacity and automated lab infrastructure. - The Business Research Company says its Global Market Model and updated forecasting tools are designed to support decision-making across the sector.

The bottom line: - Specimen sorting systems are moving from niche lab tools to a broader automation category with strong long-term growth potential.